Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 2 workshops are presently dedicated exclusively to arteriosclerotic vascular disease and about 2 articles are being published on arteriosclerotic vascular disease.
Atherosclerosis is a disease in which plaque (plak) builds up inside your arteries. Arteries are blood vessels that carry oxygen-rich blood to your heart and other parts of your body. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. . Probiotics and Atherosclerosis Atherosclerosis is the major cause of cardiovascular diseases, which are the top ten leading causes of death worldwide. Probiotics has the potential in improving atherogenesis by its anti-inflammatory effects and gut microbiota modulation thus may be used as a cheap and non-invasive alternative that brings significant health benefits. Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these disorders.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) is a specific form of arteriosclerosis in which an artery wall thickens as a result of invasion and accumulation of white blood cells (WBCs).Atherosclerosis, hardening and narrowing of the arteries .This progressive process silently and slowly blocks arteries, putting blood flow at risk. It is the usual cause of heart attacks, strokes , and peripheral vascular disease -- what together are called “cardiovascular disease” Atherosclerosis is a disease in which plaque builds up inside your arteries. Arteries are blood vessels that carry oxygen-rich blood to your heart and other parts of your body. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, plaque hardens and narrows your arteries. This limits the flow of oxygen-rich blood to your organs and other parts of your body.it can lead to serious problems, including heart attack, stroke, or even death.
Plaque may partially or totally block the blood's flow through an artery in the heart, brain, pelvis, legs, arms or kidneys. Some of the diseases that may develop as a result of atherosclerosis include coronary heart disease, angina (chest pain), carotid artery disease , peripheral artery disease (PAD) and chronic kidney disease. Treatment for atherosclerosis aims to prevent the condition from worsening to the point that it can trigger a serious cardiovascular disease, such as a heart attack. This can be achieved by making lifestyle changes, such as eating a healthier diet and increasing exercise, as well as using certain medications such as ACE inhibitors to treat high blood pressure, or statins to lower cholesterol levels.
Analysis shows that the global Atherosclerosis or Coronary Artery Disease (CAD) therapeutics market stood at $12.0 billion in 2005 and grew at a Compound Annual Growth Rate (CAGR) of 3.8% to reach $14.5 billion in 2010. Global Data forecasts that the global CAD therapeutics market will grow at a CAGR of 2.1% over the next eight years to reach $17.1 billion by 2018. The current CAD therapeutics market consists of drugs from various therapeutic classes such as statins, AngiotensinConverting Enzyme (ACE) inhibitors, Beta Blockers (BBs), antiplatelets, Calcium Channel Blockers (CCBs) and nitrates.
International symposium and workshops
1.The 3rd International Conference on Heart & Brain (ICHB 2016)
2.HEART 2015: International Symposium on Highly Efficient Accelerators and Reconfigurable Technologies
3.The 14th Annual International Symposium on Congenital Heart Disease
4.15th Annual International Symposium on Congenital Heart Disease
1. American heart association
2. Japan atherosclerosis society
3. German Atherosclerosis Society
4. The European Atherosclerosis Society
5. The Asian-Pacific Society of Atherosclerosis and Vascular Disease
6. International Atherosclerosis Society
7. Australian Atherosclerosis Society
8. British Atherosclerosis Society (BAS)
9. Japan Atherosclerosis Society
10. Iranian Society of Atherosclerosis
11. Dutch Atherosclerosis Society
1. Ache Laboratorios Farmaceuticos S/A
2. Arisaph Pharmaceuticals, Inc.
3. Artery Therapeutics, Inc.
4. Athera Biotechnologies AB
5. Athero Nova Inc.
6. AuraSense Therapeutics
8. Campus Technologies
9. Cardax Pharmaceuticals, Inc.
10. Dr. Reddy's Laboratories Limited
11. Eli Lilly and Company
12. F. HoffmannLa Roche Ltd.
13. GenKyoTex S.A.
14. Gilead Sciences, Inc.
15. Johnson & Johnson
16. KineMed, Inc.
17. Kowa Company, Ltd.
18. MedImmune, LLC
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising